Measuring illness uncertainty in men undergoing active surveillance for prostate cancer
Document Type
Article
Publication Date
2011
Abstract
Background and Purpose Uncertainty is an aversive experience and plays an important role in the lives of men undergoing active surveillance (AS; earlier referred to as watchful waiting) for early-stage prostate cancer. Yet reliable and valid measures of uncertainty have not been fully tested in this population. This secondary analysis therefore tested the reliability of the Mishel Uncertainty in Illness Scale Community Form (MUIS-C; M.H. Mishel, 1997b) for use with men undergoing AS for prostate cancer. Methods Item–Total correlations were conducted on the 23 items of the MUIS-C with four samples of men undergoing AS. Results Cronbach's alpha for the full MUIS-C was .908; 22 of 23 items showed significant positive correlations with the total score. Removing the item without a significant correlation from the reliability analysis increased Cronbach's alpha to .913. Conclusions The Mishel Uncertainty in Illness Scale—Community Form for Active Surveillance is a reliable and valid tool for measuring uncertainty with men undergoing AS for prostate cancer.
Publication Title
Applied Nursing Research
Repository Citation
Bailey, Donald E.; Kazer, Meredith Wallace; Latini, David M.; Hegarty, Josephine; Carroll, Peter; Klein, Eric A.; and Albertsen, Peter C., "Measuring illness uncertainty in men undergoing active surveillance for prostate cancer" (2011). Nursing and Health Studies Faculty Publications. 131.
https://digitalcommons.fairfield.edu/nursing-facultypubs/131
Published Citation
Bailey, D., Wallace, M., Latini, D. M., Hegarty, J., Carroll, P. R., Klein, E. A., & Albertsen, P. E. (2011). Measuring illness uncertainty in men undergoing active surveillance for prostate cancer. Applied Nursing Research, 24(4), 193-199. doi:10.1016/j.apnr.2009.08.001
DOI
10.1016/j.apnr.2009.08.001
Peer Reviewed
Comments
Copyright 2011 Elsevier
A link to full text has been provided for authorized users.